TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5551
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups ; day:11 ; month:1 ; year:2019 ; pages:1-12
Leukemia ; (11.1.2019), 1-12
- Urheber
-
Haase, Detlef
Stevenson, Kristen E.
Neuberg, Donna
Maciejewski, Jaroslaw P.
Nazha, Aziz
Sekeres, Mikkael A.
Ebert, Benjamin L.
Garcia-Manero, Guillermo
Haferlach, Claudia
Haferlach, Torsten
Kern, Wolfgang
Ogawa, Seishi
Nagata, Yasunobu
Yoshida, Kenichi
Graubert, Timothy A.
Walter, Matthew J.
List, Alan F.
Komrokji, Rami S.
Padron, Eric
Sallman, David
Papaemmanuil, Elli
Campbell, Peter J.
Savona, Michael R.
Seegmiller, Adam
Adès, Lionel
Fenaux, Pierre
Shih, Lee-Yung
Bowen, David
Groves, Michael J.
Tauro, Sudhir
Fontenay, Michaela
Kosmider, Olivier
Bar-Natan, Michal
Steensma, David
Stone, Richard
Heuser, Michael
Thol, Felicitas
Cazzola, Mario
Malcovati, Luca
Karsan, Aly
Ganster, Christina
Hellström-Lindberg, Eva
Boultwood, Jacqueline
Pellagatti, Andrea
Santini, Valeria
Quek, Lynn
Vyas, Paresh
Tüchler, Heinz
Greenberg, Peter L.
Bejar, Rafael
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41375-018-0351-2
- URN
-
urn:nbn:de:101:1-2019021500030319592882
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Haase, Detlef
- Stevenson, Kristen E.
- Neuberg, Donna
- Maciejewski, Jaroslaw P.
- Nazha, Aziz
- Sekeres, Mikkael A.
- Ebert, Benjamin L.
- Garcia-Manero, Guillermo
- Haferlach, Claudia
- Haferlach, Torsten
- Kern, Wolfgang
- Ogawa, Seishi
- Nagata, Yasunobu
- Yoshida, Kenichi
- Graubert, Timothy A.
- Walter, Matthew J.
- List, Alan F.
- Komrokji, Rami S.
- Padron, Eric
- Sallman, David
- Papaemmanuil, Elli
- Campbell, Peter J.
- Savona, Michael R.
- Seegmiller, Adam
- Adès, Lionel
- Fenaux, Pierre
- Shih, Lee-Yung
- Bowen, David
- Groves, Michael J.
- Tauro, Sudhir
- Fontenay, Michaela
- Kosmider, Olivier
- Bar-Natan, Michal
- Steensma, David
- Stone, Richard
- Heuser, Michael
- Thol, Felicitas
- Cazzola, Mario
- Malcovati, Luca
- Karsan, Aly
- Ganster, Christina
- Hellström-Lindberg, Eva
- Boultwood, Jacqueline
- Pellagatti, Andrea
- Santini, Valeria
- Quek, Lynn
- Vyas, Paresh
- Tüchler, Heinz
- Greenberg, Peter L.
- Bejar, Rafael
- SpringerLink (Online service)
Ähnliche Objekte (12)
Myelodysplastic syndromes
Myelodysplastic syndromes
Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations
Clinical characterization and prognostic impact of SF3B1 and TP53 gene mutations in myelodysplastic syndromes
Epigenetic therapy in myelodysplastic syndromes
Myelodysplastic syndromes : with 87 tabeles
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes: Where do we stand?
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes current treatment algorithm 2018
Emerging Therapies for the Myelodysplastic Syndromes
TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases
Myelodysplastic syndromes
Myelodysplastic syndromes
Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations
Clinical characterization and prognostic impact of SF3B1 and TP53 gene mutations in myelodysplastic syndromes
Epigenetic therapy in myelodysplastic syndromes
Myelodysplastic syndromes : with 87 tabeles
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes: Where do we stand?
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes current treatment algorithm 2018
Emerging Therapies for the Myelodysplastic Syndromes
TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases
Myelodysplastic syndromes
Myelodysplastic syndromes
Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations
Clinical characterization and prognostic impact of SF3B1 and TP53 gene mutations in myelodysplastic syndromes
Epigenetic therapy in myelodysplastic syndromes
Myelodysplastic syndromes : with 87 tabeles
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes: Where do we stand?
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes current treatment algorithm 2018
Emerging Therapies for the Myelodysplastic Syndromes